|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 413/12 | |
| A61K 31/422 | |||
| A61K 31/4245 | |||
| C07D 417/12 | |||
| A61P 3/00 | |||
| A61P 3/04 | |||
| A61P 3/10 |
| (11) | Patento numeris | 2852590 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13727385.0 |
| Europos patento paraiškos padavimo data | 2013-04-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-02-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/053292 |
| Data | 2013-04-25 |
| (87) | Numeris | WO 2013/160873 |
| Data | 2013-10-31 |
| (30) | Numeris | Data | Šalis |
| 201261639341 P | 2012-04-27 | US | |
| PCT/CN2013/0727 | 2013-03-15 | WO | |
| 201361787695 P | 2013-03-15 | US |
| (72) |
CHEN, Xin, US
DING, Yiping, CN
DUVADIE, Rohit, US
GAI, Yu, CN
HARRISON, Tyler, US
LIU, Qian, US
LARROW, Jay, US
MAO, Justin Yik Ching, US
PATEL, Sejal, US
YE, Jiong, CN
ZECRI, Frederic, US
ZHENG, Xuchun, CN
ZHENG, Rui, US
ZHOU, Yizong, CN
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS |
| CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS |